Market Size
The Global Humanoid Robots in Healthcare Market reached US$ 1,061.07 million in 2025 and is expected to reach US$ 11,411.60 million by 2033, growing at a CAGR of 34.5% during the forecast period 2026-2033.
Humanoid robots are artificial human-like machines built to mimic human-like activities and interactions. These are the most advanced forms of robots in the current world, finding their applications in manufacturing, warehousing & logistics, construction, hospitality & entertainment, healthcare, and general services. These advanced robots are currently utilized in the healthcare industry as companions in elderly care, for vital parameter recording and monitoring in hospitalized and home-based patients, and for assistance in general activities in the hospital.
Market Scope
| Metrics | Details |
| CAGR | 34.5% |
| Market Size | 2023-2033 |
| Market Estimation Forecast Period | 2026-2033 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Movement Type, Application, and End Users |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers
Rising investments in robotics
In the current world, humanoid robots are the most advanced robots that are gaining huge popularity due to their ability to function and think like humans. The humanoid robots have already been deployed in various industries such as manufacturing, warehousing & logistics, hospitality, and entertainment. In the healthcare industry, these humanoid robots are still finding their applications, and only a limited number of companies have commercialized their robots. However, healthcare is the most promising sector for the future of humanoid robots, and the investments and funding are rising from the manufacturers and governments to develop and deploy them. These investments and funding are primary contributing factors to the market growth in the forecast period.
For instance, in November 2023, a new Humanoid Robot Innovation Center was established in Beijing with the support of the Beijing government. Within a year of its establishment, the center has produced a new humanoid robot called Tien Kung. The general manager of Humanoid Robot Innovation Center, Mr. Rick Xiong has stated that humanoid robotics will be applied on a larger scale at home in the next three to five years.
In addition, Sanctuary AI, an innovation-driven humanoid robot development company has raised US$ 140 million in funding from various investors till July 2024. The company received a US$ 30 million strategic innovation fund from the Canadian government earlier in 2022. Sanctuary AI aims to utilize these funds to accelerate its innovation in AI (artificial intelligence) and humanoid robotics.
There are several companies which are at the innovation stage and are hugely receiving funding from government and private sectors. This funding will be utilized by them for the development of advanced humanoid robots, which may also expand their footprint in the healthcare sector.
Restraints
The market for humanoid robots in healthcare is restrained by several factors such as the limited availability of humanoid robots, limitations of humanoid robot applications, high cost, etc. At present the humanoid robots majorly find their application as a companion for elderly care, collecting patient details and vital parameters, and assisting in general hospital activities. Moreover, resistance by the elderly due to technological ambiguity may also restrain their utilization of their care services.
For more details on this report - Request for Sample
Market Segment Analysis
The global humanoid robots in healthcare market is segmented based on movement type, application, end users, and region.
Elderly care in the application segment accounted for approximately 54.3% of the global humanoid robots market share
Humanoid robots are currently used in the healthcare industry mainly for elderly care. They find their application in assisting them in day-to-day activities, providing companionship, helping them to communicate, measuring their vital signs, scheduling appointments with doctors, etc. These robots are highly intelligent and can understand human emotions, and expressions and respond like a human. They actively engage seniors in the home, care facilities, and hospitals through physical assistance, guiding them in exercises, recognizing their emotions and creating a cheerful environment, providing companionship in improving their cognitive ability, etc.
The popular humanoid robot “Pepper” developed by SoftBank Robotics Group, and “PALRO” by FUJISOFT Inc. majorly find their application in providing elderly care. However, these robots are not just limited to elderly care applications, they can also be customized and trained for other applications in the healthcare industry. Similarly, the other robots like Prombot, Moxi, aeo, and Abi are not limited to hospital assistance, and vital parameter monitoring, they can also be trained for other healthcare applications.
| S.No | Robot | Manufacturer | Application |
| 1 | Pepper | SoftBank Robotics Group. | Appointment Scheduling, Elderly Care |
| 2 | Prombot | Prombot | Vital Parameter Monitoring |
| 3 | PALRO | FUJISOFT Inc | Elderly Care |
| 4 | Moxi | Diligent Robotics Inc. | Hospital Assistance |
| 5 | aeo | Aeolus | Hospital Assistance |
| 6 | Abi | andromeda. | Companion for Elderly and Children in Hospitals |
Market Geographical Analysis
Asia-Pacific in global humanoid robots in healthcare market is expected to grow with the highest CAGR of 23.7% in the forecast period
Asia-Pacific region is experiencing significant growth in the humanoid robots in the healthcare market due to higher research and development activities across industries, and research institutes especially in China and Japan. These countries are well known for their investments in industrial automation and currently have the technology to develop and deploy humanoid robots in the healthcare industry for various applications. At present the market leaders in humanoid robots dedicated to healthcare, arise from Japan and China. Pepper, which is the most famous humanoid robot was developed by a Japanese company SoftBank Robotics Group. Pepper is currently serving senior care facilities in Japan.
Moreover, according to the International Trade Administration, Japan has 631 working robots for every 10,000 humans, and the U.S. has only 274 robots per 10,000 humans in 2021. By 2065, the workforce in Japan is expected to decline by 40%, which projects a higher demand for humanoid robots.
China is also at the forefront of humanoid robot development. Several companies and research facilities are actively involved in the development. A Shangai-based company “Dataa Robotics” is actively involved in developing and deploying humanoid robots all across the world. The company has commercialized its robots since 2017. Moreover, one of the leading companies in the humanoid robotics market, i.e., UBTECH originated from China and has expanded business in the country and across the globe. There are several such companies in China, majorly located in Beijing, which are driving innovations in the robotics field.
Market Segmentation
By Movement Type
- Bipedal
- Wheeled
By Application
- Vital Parameter Monitoring
- Appointment Scheduling
- Elderly Care
- Hospital Assistance
- Others
By End Users
- Hospitals & Clinics
- Medical Universities
- Homecare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Key Developments
February 2026: Rising adoption of AI-powered humanoid robots for patient monitoring, elderly assistance, and hospital automation accelerated innovation in the global Humanoid Robots in Healthcare market. Healthcare providers increasingly deployed humanoid systems to address workforce shortages and improve operational efficiency across hospitals and long-term care facilities.
January 2026: Increasing investments in robotics, artificial intelligence, and digital healthcare infrastructure strengthened development of advanced humanoid healthcare robots worldwide. Companies expanded integration of conversational AI, autonomous navigation, and telepresence capabilities to support clinical and non-clinical healthcare applications.
December 2025: Growing demand for elderly care support and rehabilitation assistance accelerated commercialization of humanoid healthcare robots globally. Healthcare institutions increased adoption of robots capable of medication reminders, mobility assistance, emotional interaction, and patient engagement functions.
November 2025: Expansion of smart hospital initiatives and healthcare automation programs across North America, Europe, and Asia-Pacific strengthened deployment of humanoid robots in medical environments. Hospitals increasingly adopted robotic systems for logistics support, patient guidance, and routine healthcare assistance tasks.
October 2025: Rising advancements in machine learning, computer vision, and robotic dexterity improved functionality and safety of humanoid healthcare robots worldwide. Research institutions accelerated development of teleoperated humanoid systems capable of supporting clinical examinations and minimally invasive medical procedures.
September 2025: Increasing collaborations between robotics companies, healthcare providers, and research organizations accelerated innovation in humanoid healthcare technologies globally. Strategic partnerships focused on rehabilitation robotics, remote patient care, and intelligent hospital automation platforms.
August 2025: Growing healthcare workforce shortages and aging population trends strengthened demand for humanoid robots in elderly care and assisted living applications worldwide. Governments and healthcare organizations expanded investments in robotic caregiving technologies to improve healthcare accessibility and long-term patient support.
July 2025: Rising focus on AI-enabled healthcare assistants, emotional support robots, and autonomous care systems accelerated innovation in humanoid robotics platforms globally. Companies expanded development of robots supporting pediatric therapy, dementia care, and patient communication applications.
June 2025: Increasing focus on healthcare automation, precision robotics, and digital transformation supported strong growth in the global Humanoid Robots in Healthcare market. North America maintained technological leadership, while Asia-Pacific emerged as a rapidly growing region driven by strong robotics adoption, aging populations, and expanding healthcare investments.
Market Competitive Landscape
The major players in the humanoid robots in healthcare market include SoftBank Robotics America, Inc., Promobot, FUJISOFT Inc, Hanson Robotics Ltd., Diligent Robotics Inc., Aeolus, andromeda., Asimov Robotics., UBTECH ROBOTICS CORP LTD., and Dataa Robotics among others.
Why Purchase the Report?
- To visualize the global humanoid robots in healthcare market segmentation based on movement type, application, end users, and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of humanoid robots in the healthcare market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global humanoid robots in healthcare market report would provide approximately 62 tables, 54 figures, and 175 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
